Clinical Scorecard: Limited utility of [99mTc]-sestamibi scintigraphy in patients with primary hyperparathyroidism and negative ultrasound results

At a Glance

Key Highlights

• Surgical removal of hyperfunctioning parathyroid glands is curative in >97% of cases.
• Preoperative imaging including ultrasound and [99mTc]-sestamibi scintigraphy is standard but may have limited utility if ultrasound is negative.
• Focused surgical approaches guided by imaging reduce morbidity compared to bilateral exploration but depend on accurate localization.

Guideline-Based Recommendations

Diagnosis

• Diagnosis based on elevated serum calcium adjusted for albumin and elevated or inappropriately normal intact PTH after excluding familial hypocalciuric hypercalcemia.
• Neck ultrasound is the first-line imaging modality for localization.
• [99mTc]-sestamibi scintigraphy is commonly used following ultrasound to confirm adenoma localization or exclude ectopic glands.
• Extended imaging (e.g., [11C]-methionine or [11C]-choline PET/CT) may be considered if initial imaging is negative.

Management

• Surgical removal of hyperfunctioning glands is the only curative treatment.
• Focused parathyroidectomy is preferred when localization is successful to reduce morbidity.
• Bilateral surgical exploration is reserved for cases with negative or inconclusive imaging.

Monitoring & Follow-up

• Intraoperative PTH monitoring to confirm successful removal defined by >90% drop or PTH <35 pg/ml after 15 minutes.
• Postoperative serum calcium and PTH levels to assess cure and detect hypocalcemia.

Risks

• Negative preoperative imaging correlates with reduced surgical success rates.
• Bilateral exploration carries higher risks of recurrent nerve palsy, permanent hypoparathyroidism, and bleeding compared to focused surgery.

Patient & Prescribing Data

Patients with primary hyperparathyroidism undergoing surgery with preoperative imaging

Preoperative imaging guides surgical approach; negative ultrasound limits utility of [99mTc]-sestamibi scintigraphy, potentially necessitating extended imaging or bilateral exploration.

Clinical Best Practices

• Use high-resolution neck ultrasound as first-line imaging for parathyroid adenoma localization.
• Perform [99mTc]-sestamibi scintigraphy following ultrasound to confirm adenoma site or detect ectopic glands.
• Consider advanced PET/CT imaging ([11C]-methionine or [11C]-choline) if both ultrasound and sestamibi scintigraphy are negative.
• Employ intraoperative PTH monitoring to verify successful adenoma removal.
• Opt for focused parathyroidectomy when localization is successful to minimize surgical morbidity.
• Reserve bilateral neck exploration for cases with negative or inconclusive imaging findings.

References

• Primary hyperparathyroidism diagnosis and treatment guidelines
• Surgical success rates and intraoperative PTH monitoring
• Imaging modalities for parathyroid adenoma localization